Table 3: Outcomes and likelihood ratios.
|
MRS Group 1 |
MRS Group 2 |
MRS Group 3 |
MRS Group 4 |
||||
Reuter |
Mehran |
Reuter |
Mehran |
Reuter |
Mehran |
Reuter |
Mehran |
|
Patients (n) |
508 |
2486 |
283 |
1633 |
114 |
599 |
26 |
154 |
CIN (%) |
5.7 |
7.5 |
13.1 |
14 |
30.7 |
26.1 |
50 |
57.3 |
HD (%) |
0 |
0.04 |
0.4 |
0.12 |
0.9 |
1.09 |
7.7 |
12.6 |
LR CIN |
0.4 |
0.5 |
1.1 |
1.0 |
3.2 |
2.3 |
7.2 |
8.5 |
LR HD |
0 |
0.07 |
0.8 |
0.2 |
2.1 |
2.0 |
19.3 |
23.5 |
LR Mortality |
0.3 |
0.3 |
0.9 |
1.0 |
4.3 |
3.0 |
6.3 |
7.5 |